-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Reiterates Market Outperform on Kura Oncology, Maintains $28 Price Target

Benzinga·06/04/2025 13:40:30
Listen to the news
JMP Securities analyst Reni Benjamin reiterates Kura Oncology (NASDAQ:KURA) with a Market Outperform and maintains $28 price target.